Search:

To be the North American leader in neurology through the quality of our people, the quality of our products, and our focus on the patient.

Personal commitment
High integrity
Strong teamwork
Achievement oriented
Create opportunity
Sense of satisfaction

At Teva Neuroscience, we strive to be the place where our culture, values and opportunities contribute to attract the highest quality individuals. We are interested in considering candidates who are a fit with the Company's culture and values for all positions.

Teva Neuroscience: "The place where the best people choose to work"

HOME

SITE MAP

You need Adobe Flash Player to properly view this page. Please install Flash Player here

Company Background

Teva Neuroscience, Inc. markets COPAXONE^® (glatiramer acetate injection) and AZILECT^® (rasagiline tablets).

Teva Neuroscience offers a total approach to disease management and has established several innovative and effective patient education and advocacy programs. These include Shared Solutions^®
(1-800-887-8100), a premier support program for MS patients and online support at SharedSolutions.com.

Teva Neuroscience has forged strong partnerships with neurologists and professional organizations also dedicated to supporting and improving the lives of people with MS, including the American Academy of Neurology (AAN), the International Organization of MS Nurses (IOMSN), Women Neurologists' MS Initiative (WNMSI), and the National MS Society (NMSS).

Teva Neuroscience is a subsidiary of Teva Pharmaceutical Industries Ltd.

COPAXONE^® Important Safety Information

COPAXONE^® Additional Important Information

AZILECT^® Important Safety Information

AZILECT^® Additional Important Information

Please read also

086463114/080423

COPAXONE® (glatiramer acetate injection) is a registered trademark of Teva Pharmaceutical Industries Ltd.
AZILECT® (rasagiline tablets) is a registered trademark of Teva Pharmaceutical Industries Ltd.
Shared Solutions® is a registered trademark of Teva Neuroscience, Inc.

This site is intended for U.S. audiences only